Novartis
Novartis is seeking a translational modeler to accelerate oligonucleotide therapeutics from discovery through clinical translation. The role involves partnering with discovery, preclinical, clinical pharmacology, and pharmacometrics teams to develop and apply mechanistic PK/PD, QSP, and PBPK/PD models that inform program strategy, dose optimization, and lifecycle management.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
5% below the average for this role
Associate Director, PBPK-PD Translational Modeling, DMPK
GSK plc
Scientific Associate Director
MSD
Sr. Manager, Translational Modeling
BioCryst Pharmaceuticals
Preclinical PK/PD Modeler / Quantitative Pharmacology Scientist
Ridgeline Discovery GmbH
PKPD modelling scientist
ChemoMetec
DMPK and Clinical Pharmacology Scientist
GondolaBio Service Co, Inc.